Pharmaceutical

Futura Medical and Haleon partner to commercialise Eroxon gel in US

UK-based Futura Medical has signed a deal with Haleon to commercialise its OTC erectile dysfunction gel, Eroxon, in the US.

Jul 17, 2023 - 20:00
Futura Medical and Haleon partner to commercialise Eroxon gel in US
UK-based Futura Medical has signed a deal with Haleon to commercialise its OTC erectile dysfunction gel, Eroxon, in the US.
Read the original article

Tags:

Previous Article

STAT+: After FDA nod, Better Therapeutics races to boost dwindling cash

Next Article

FDA expands Veklury’s use to Covid-19 patients with severe kidney disease

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Study proposing microbiome-based cancer diagnostic comes under fire

STAT+: Study proposing microbiome-based cancer diagnost...

Aug 3, 2023

STAT+: An ultrasound device may unlock brain cancer treatment, early study shows

STAT+: An ultrasound device may unlock brain cancer tre...

May 15, 2023

STAT+: ‘Missed opportunities’: Why a U.K. government plan to disclose financial ties between pharma and docs may fall short

STAT+: ‘Missed opportunities’: Why a U.K. government pl...

Oct 24, 2023